Cargando…
Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs
The COVID-19 pandemic has disrupted life throughout the world. Newly developed vaccines promise relief to people who live in high-income countries, although vaccines and expensive new treatments are unlikely to arrive in time to help people who live in low-and middle-income countries. The pathogenes...
Autores principales: | Byttebier, Geert, Belmans, Luc, Alexander, Myriam, Saxberg, Bo E. H., De Spiegeleer, Bart, De Spiegeleer, Anton, Devreker, Nick, Van Praet, Jens T., Vanhove, Karolien, Reybrouck, Reinhilde, Wynendaele, Evelien, Fedson, David S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171011/ https://www.ncbi.nlm.nih.gov/pubmed/34047686 http://dx.doi.org/10.1080/21645515.2021.1920271 |
Ejemplares similares
-
Adjunctive Use of Statins for COVID-19
por: Sathekge, Mike, et al.
Publicado: (2021) -
The Effects of ARBs, ACEis, and Statins on Clinical Outcomes of COVID-19 Infection Among Nursing Home Residents
por: De Spiegeleer, Anton, et al.
Publicado: (2020) -
Faecal microbiota transplantation: a regulatory hurdle?
por: Verbeke, Frederick, et al.
Publicado: (2017) -
Degradation kinetics of artesunate for the development of an ex-tempore intravenous injection
por: Gashe, Fanta, et al.
Publicado: (2022) -
Influence of Blood Collection Methods and Long-Term
Plasma Storage on Quorum-Sensing Peptide Stability
por: Debunne, Nathan, et al.
Publicado: (2020)